Home Featured Page 263

Featured

Latest

A Crucible of Academia, Psychedelics, and Religion: Psychedelic Intersections 2025 at The Harvard Divinity School

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in Parliamentary Report

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

Exploring Psychedelist with Louis Dorian

‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU

Red Light Holland iMicrodose Pack Receives Authorization for the First Legal...

Yukoterre Announces Conditional Approval of Reverse Takeover Transaction With Silo Wellness

PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney...

Nova Mentis Autism Clinical Study Approved by Institutional Review Board

The Effects of Antidepressant Discontinuation on MDMA-Assisted Psychotherapy

Should You Listen to Music During Psychedelic Treatments? How Sounds Impact...

Will the Biden Administration Embrace Federal Psychedelic Reform?

1...262263264...281 Page 263 of 281

A Crucible of Academia, Psychedelics, and Religion: Psychedelic Intersections 2025 at...

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

A Crucible of Academia, Psychedelics, and Religion: Psychedelic Intersections 2025 at The Harvard Divinity School

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in Parliamentary Report

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

Exploring Psychedelist with Louis Dorian

‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU

Red Light Holland iMicrodose Pack Receives Authorization for the First Legal...

Yukoterre Announces Conditional Approval of Reverse Takeover Transaction With Silo Wellness

PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney...

Nova Mentis Autism Clinical Study Approved by Institutional Review Board

The Effects of Antidepressant Discontinuation on MDMA-Assisted Psychotherapy

Should You Listen to Music During Psychedelic Treatments? How Sounds Impact...

Interview With Christi Myers

Interview With Ronan Levy

Will the Biden Administration Embrace Federal Psychedelic Reform?

EDITOR PICKS

A Crucible of Academia, Psychedelics, and Religion: Psychedelic Intersections 2025 at...

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY